KING OF PRUSSIA, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) today announced that it will host an Investor Day on Wednesday, March 19, in Philadelphia, PA. The event will ...

Shares of Vertex Pharmaceuticals Inc. VRTX rose 1.45% to $495.42 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

The latest open-source AI models from Google can either be deployed locally, or through the company’s cloud-based platforms such as the Vertex AI suite. Gemma 3 AI models are now available via ...

and Google Cloud Vertex. In its initial shape, Moto AI offered a Magic Canvas tool that turns text descriptions into creative images, alongside a Style Sync feature that creates wallpapers based ...

Vertex Pharmaceuticals (VRTX) reachead $495.29 at the closing of the latest trading day, reflecting a +1.42% change compared to its last close. We recently published a list of the 11 Best Pharma ...

The drug is Journavx by Vertex Pharmaceutical and the drug was approved by the FDA on Jan 30 th, 2025. The company is also facing loss of exclusivity in 2027 from the Nucynta drugs. The ability to ...